District of Columbia: Belviq (lorcaserin… | DrugsMonitor.com

Belviq (lorcaserin) litigation in District of Columbia (DC): Allegations recap, procedure at a glance, next steps—not legal advice.

lorcaserin, weight management drug, market withdrawal, cancer signal studies, District of Columbia